SEC Form 4 · accession 0001615774-15-002783
Enumeral Biomedical Holdings, Inc. · ENUM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur H. Tinkelenberg
Officer — President and CEO · Director
Period of report
Sep 28, 2015
Accepted (ET)
Sep 30, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561551
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option (Right to Buy)F1 | $0.36 | Sep 28, 2015 | A | 880,000 | A | — | Sep 27, 2025 | Common Stock | 880,000 | 880,000 | D |
Explanation of responses
- F1The option vests as follows: (a) 440,000 shares underlying the option vest and become exercisable in 48 consecutive monthly installments on the 28th day of each month, with the first installment on October 28, 2015; (b) 220,000 of the shares underlying the option shall vest and become exercisable, if at all, upon the achievement of certain performance criteria; and (c) 220,000 shares underlying the option shall vest and become exercisable, if at all, upon the achievement of certain other performance criteria.